The possibility of inducing long-term protection against prostate cancer by vaccination may cause a "major paradigm shift"

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1633, 2008-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term immunosuppressant use may be linked to cancer

By  

Reactions Weekly, Vol. 1, Iss. 1329, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Long-term pioglitazone use may be linked to bladder cancer

By  

Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Long-term goserelin does not deprive prostate cancer patients

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Prospects for Vaccination in Prostate Cancer

By Perry M.J.A.   Hrouda D.   Dalgleish A.G.  

Drugs & Aging, Vol. 16, Iss. 5, 2000-05 ,pp. : 321-327

Adis International

Access to resources Recommend Favorite

Protection against -amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice

By Yan J.-J.   Kim D.-H.   Moon Y.-S.   Jung J.-S.   Ahn E.-M.   Baek N.-I.   Song D.-K.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 25-30

Elsevier

Access to resources Recommend Favorite